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Abstract: A new LD (Laser Diode) was developed to 
specifically excite protoporphyrin IX (PpIX), a 
photochemotherapeutic agent that is selectively produced in 
human tumor tissues following administration of 5-
aminolevulinic acid (5-ALA), as well as its photoproduct. 
PpIX emits red fluorescence if it is exposed by the blue light 
(410 nm) of the laser. During fluorescent diagnosis, the 2 
wavelengths of red excitation (635 and 665 nm) from the LD 
laser were both exposed to the tumor at the same time. Both 
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wavelengths were effectively absorbance matched for the 
PpIX and the photoproduct produced during irradiation.  
There is an overlap in the spectral characteristics of the PpIX 
absorbance and emission.  Both processes occur at 635 nm.  
As such, a continuous wave laser cannot excite PpIX and  
monitor its emission simultaneously.  We therefore 
developed a pulsed CW laser that could time gate between the 
blue and red lights, enabling us to both excite and monitor the 
PpIX at the same time. In future, this laser will be used in a 
risk assessment protocol for the treatment of elderly patients 
and to also assess the relative cost this treatment in 
comparison with other cancer treatments. 
Introduction:  
5-aminolevulinic acid (5-ALA) is a precursor of heme, synthesized from 
succinyl coenzyme A and glycine. It contributes to a chain of porphyrin 
intermediates (porphobilinogen, uroporphyrinogen and coproporphyrinogen) 
leading to mitochondrial generation of protoporphyrin IX (PpIX) using 8 
molecules of 5-ALA. The latter is then enzymatically converted to heme via 
ferrochelatase. These reactions briskly proceed in the liver and in erythrocyte 
precursors even in healthy individual but are augmented in rapidly proliferating 
cells. The usage of 5-ALA dosing, metabolism typically halts at 
porphobilinogen (PBG) due to rate-limiting PBG deaminase activity. However, 
the rate-limiting step in more active tumor cells shifts to ferrochelatase, so that 
Pp-IX accumulates instead and it is the accumulation of PpIX that responds to 
ultraviolet light, emitting a red fluorescence. Furthermore, we observed that 
PpIX fluorescence was enhanced by adding a NO generator, S-nitroso-N-
acetylpenicillamine (SNAP), whereby the NO radical blocks the ferrochelatase 
enzyme activity.  
First generation laser systems, such as eximer-dye lasers, an OPO-lasers and argon - 
dye lasers have been used as excitation sources in clinical photodynamic therapy (PDT) 
during the past 20 years .  The high purchase and maintenance cost of these older lasers 
have become problematic for clinical applications. Laser diodes (LD), such as the one 
emitting at 664 nm (Panasonic, Ltd. Co., Tokyo) shows some promise in PDT, but is 
limited to a single wavelength.  
During ALA-PDT, the absorption of the photosensitizer in the tumor tissue will 
actually undergo a change in absorbance characteristics during the irradiation period. 
Ideally, the wavelength(s) produced by the excitation laser should also be capable of 
exciting the modified photosensitizer. The two principle excitation wavelengths for PpIX 
are 410 nm (Soret band) and 635 nm (Q-band).  In addition, it is now known that the 
PpIX photoproduct, produced during the initial phase of PpIX photoexcitation either at 
410 or 635 nm, has an absorbance peak at 665 nm (3).  A further complication is that 
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635 nm is both at an absorption and emission peak of PpIX   Thus, one would like to be 
able to separate the absorbance process from the emission process, especially during the 
photodetection/photodiagnostic (PD) phase.  The new LD laser used in this study has 
three excitation wavelengths, 410 nm, 635nm and 665 nm, corresponding to the main 
absorbance peaks of PpIX as well as the absorbance peak of the PpIX photoproduct. 
Further, in order to separate the absorbance process from the fluorescence process, one 
can time gate (pulsed timing delay) the laser so as to separate the absorbance 
phenomenon from the fluorescence process. The 3 wavelengths LD-laser was pulsed for 
the timing of the fluorescent diagnosis and the PDT treatment in order to remove the 
fluorescence and irradiation wavelength overlapped at the same wavelength (635 nm). 
One can thus separate the red fluorescent emission and the PDT irradiation at 635 nm 
through the pulsed trimming delay. 
 
Experimental and Methods: 
(1) Photoproduct during PDT irradiation. 
The excitation spectra  of all absorbing species in 105 cells/ml HL-60 cell 
(human leukemia) suspension incorporated 0.1 mM 5-ALA for 30 min 
incubation  was obtained by monitoring at the 635 nm fluorescent peak and 
changing the excitation wavelength using a fluorescence spectrophotometer 
(Type-850, Hitachi Ltd., Co., Tokyo) as shown in Figure 1. The excitation 
spectrum of (A) was in the case of before irradiation and (B) was after 
irradiation (40 J/cm2) at 630 nm, respectively.  The (B) spectrum was changed 
at the Q-band of the porphyrin, specifically showing a decrease of the excitation 
peak intensity at 635 nm with a corresponding increase at 665 nm. The new 
peak of 665 nm is probably a chrorin-E6 type of PpIX derivative, as shown in 
the Diels-Alder reaction in Figure 1. 
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Changing Spectra of Pp-IX Photoproduct during Photoirradiation
 [Figure 1] The excited fluorescent spectra of Pp-IX and the photoproduct 
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produced before (A spectrum) and during (B spectrum) irradiation at 630 nm  
(40 J/cm2) against the Pp-IX molecules incorporated in the HL-60 cultivated 
cell suspension (The upper chemical reaction of Diels-Alder type) is speculated 
to produce the isomer molecules of Chorine E6 derivatives. 
 
In actual, the excitation peak at 630 nm was decreasing with increasing the 
excitation peak at 665 nm during the photo-irradiation. As it has been reported 
about the photoproducts of Pp-IX by many researchers, chlorine derivative by 
Moan group (4, 5, 6), we can also estimate that it will be a chlorine-like 
derivative from the matting with the excitation (665 nm) and emission (670 nm) 
peaks of the derivative. Furthermore, the product plays photoactive as a 
photosensitizer as following figures. On the other hand, it was reported that the 
photoproduct will a hydroxyl aldehyde derivative of Pp-IX reported by Dietel, 
et al. (7) as the product of Pp-IX. 
 
Results  
The prototype of 3 wavelength pulsed LD-laser is shown at Figure 2, which 
includes a pulse generator for the three wavelengths (410, 635 and 665 nm) LD 
laser at 10 kHz.  The maximum output power for these three wavelengths was 
more than 150 mW/cm2 at 4 kHz. The time-dependent profile for these 
wavelength output are shown in Figure 3.  The delay time between pulses was 
38 sec for both 635 and 665 nm). 
 
36
 PD and PDT in PACIFICHEM2010   Printed 2011/06/30  5 
[Figure 2] Proto-type of progressed LD pulsed triple wavelength laser/ 
Pulse generator box and Triple wavelength laser (410, 635, and 665 nm) box. 
410 nm laser: for the fluorescent diagnosis (PD) to be excited by Pp-IX 
molecules incorporated in tumor cells and tissue. 
635 and 665 nm laser: for the photodynamic therapy of tumor cells and tissue to 
photosensitize with Pp-IX and the photoproduct. 
 
 
Timing of Pulsed (410-635 nm)
Timing of Pulsed (635-665 nm)
100 s
38s38s
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410 nm CW Laser (200mW/cm2)
636/665 nm CW Laser (200mW/cm2)
(410nm)
(635nm)
(635nm)
(665nm)
 [Figure 3] The shape of timing control of the excitation and irradiation pulses. 
(Left side)=CW laser, (Right side)= Pulsed timing of excitation at 410nm and 
irradiation at 635 and 665 nm. The lag time between the excitation and the 
irradiation is 38 sec at 10 kHz. Each pulses are 12 sec at 10 kHz. 
 
In living animal experiments, both of the excitation and treatment 
irradiation were done successfully as shown in each photograph, excitation and 
treatment irradiation of experimental tumor model nude mouse, which were 
explanted with human prostate cancer (grade-IV) cell line (PC-3: with cell 
density 1 x 106 cells) under the skin (subcutaneous injection) of the femur at 4 
hours after the oral administration of 1 mM 5-ALA saline solution.  The 
fluorescent red emission was observed by the excitation of LD laser at 410 nm 
and at 4 kHz pulsed. The irradiation of 2 wavelength for 4 kHz pulsed laser 
light for PDT was confirmed  as the right photograph in Figure 4 by a time-
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dependent camera (Streak Camera Type, Hamamatsu Photonics, Ltd. Co. 
Hamamatsu). The distribution of the red fluorescent image was a close match to 
the part of tumor tissue in the left photograph. Furthermore, the tumor region 
was focused by the irradiated red-lights of 635 and 665 nm independent of the 
fluorescent region. The dose of treatment was 150 J/cm2 for changing the color 
of dark red and edema in all areas of tumor tissue at 12 hr after the irradiation. 
 
Discussion  
The photos shown in Figure 4, clearly show the ability of the three 
wavelength LD laser to monitor the PDT treatment via its fluorescence 
diagnosis simultaneously while excitation is taking place, as observed on the 
monitor. This novel laser system can thus be very useful for both the treatment 
and photodiagnosis of PDT.  It is our hope that this new system will provide an 
easy to use system capable of producing reproducible results for the monitoring 
of tumor tissues of various types at different stages of the PDT treatment.  
Furthermore, the survival rate of the tumor model mice can be assessed with 
such a system.  
 [Figure 4] Photograph of fluorescent photo detection (PD) image 
 and irradiated image of the tumor tissue (a human prostate cancer model  
nude mouse) transplanted the cell line (PC-3). 
These images were observed by a streak camera (C-5680 type; Hamamatsu Ltd. 
Co, Hamamatsu.) for each different  pulses. 
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